Welcome to the international HTA database

Showing [3321 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2021	Ontario Health	Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2021	Ontario Health	Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure
2021	Ontario Health	Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment
2021	Ontario Health	Pigmented lesion assay for suspected melanoma lesions
2021	Ontario Health	Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression
2021	Ontario Health	Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers
2021	Ontario Health	Prostatic artery embolization for benign prostatic hyperplasia
2021	Ontario Health	Nonthermal endovenous treatments for varicose veins
2021	Ontario Health	Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment
2021	Ontario Health	DPYD Genotyping in Patients Who Have Planned Cancer Treatment With Fluoropyrimidines
2021	Ontario Health	iStent for Adults With Glaucoma: A Health Technology Assessment
2021	Ontario Health	Internet-delivered cognitive behavioral therapy for post-traumatic stress disorder and acute stress disorder
2021	Ontario Health	Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment
2020	Institute of Health Economics (IHE)	Urgent care models to bridge emergency and primary care
2020	Institute of Health Economics (IHE)	The effectiveness of community face mask use for the prevention of COVID-19 transmission and infection
2020	Institute of Health Economics (IHE)	COVID-19 transmission from and infection of children
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Field evaluation of the implementation of video teleconsultations during the COVID-19 pandemic at the Quebec Heart and Lung Institute]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Exploratory evaluation of the relevance, use, and impacts of teleconsultations]
2020	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Proposal for the organization of bariatric medicine for the territories of the integrated university health and social services network of Laval University]
2020	Canadian Agency for Drugs and Technologies in Health (CADTH)	Condition-level review on tuberculosis: repository of evidence and resources
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in clinical immunology]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in hematology]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: recommendations concerning the information required to monitor nusinersen use in real-world settings]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: RebinynTM (nonacog beta pegol) – coagulation factor IX (recombinant), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec, an evaluation in the real-world context of care, 2013 to 2018]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: iStent® and iStent inject® trabecular bypass for micro-invasive glaucoma surgery (MIGS)]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: update of the systematic review of the effects of palivizumab prophylaxis on reducing complications associated with respiratory syncytial virus infections in children]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: safety of switching biologics and their interchangeability]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary: investigation, treatment and follow-up algorithm - lung cancer]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rapid review: alternatives to timolol for the treatment of glaucoma]
2020	Technology Assessment at SickKids (TASK)	Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020	Ontario Health	Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2020	Ontario Health	Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020	Ontario Health	Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020	Ontario Health	Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment
2020	Ontario Health	Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment
2020	Ontario Health	5-Aminolevulinic Acid Hydrochloride (5 ALA)–Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment
2020	Ontario Health	Extracorporeal Membrane Oxygenation for Cardiac Indications in Adults: A Health Technology Assessment
2020	Ontario Health	Continual Long-Term Physiotherapy After Stroke: A Health Technology Assessment
2020	Ontario Health	10-kHz high-frequency spinal cord stimulation for adults with chronic noncancer pain: a health technology assessment
2020	Ontario Health	Cell-Free Circulating Tumour DNA Blood Testing to Detect EGFR T790M Mutation in People With Advanced Non–Small Cell Lung Cancer: A Health Technology Assessment
2020	Ontario Health	Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment
2020	Ontario Health	Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2020	Ontario Health	Implantable devices for single-sided deafness and conductive or mixed hearing loss: a health technology assessment
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2019	Institute of Health Economics (IHE)	Clinical effectiveness and cost-effectiveness of Oncotype DX and Prosigna genetic testing in early-stage breast cancer
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Evaluation of the effectiveness and cost effectiveness of cardiac rehabilitation programs]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Induction immunosuppressive therapy in patients undergoing heart transplantation]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Measurement of gastric residual volume during enteral feeding in patients hospitalized in the intensive care unit]
2019	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Use of incentive spirometry for the prevention of pulmonary complications following surgery]
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Flash glucose monitoring system for people with type 1 or type 2 diabetes: a health technology assessment
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Genome-wide sequencing: ethical considerations
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Axicabtagene ciloleucel for large B-cell lymphoma: clinical report
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Internet-delivered cognitive behavioural therapy for major depressive disorder and anxiety disorders: a health technology assessment
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	HPV testing for primary cervical cancer screening: a health technology assessment
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Community water fluoridation programs: a health technology assessment - review of dental caries and other health outcomes
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dual antiplatelet therapy following percutaneous coronary intervention: clinical and economic impact of standard versus extended duration
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal use of minimally invasive glaucoma surgery: a health technology assessment
2019	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tisagenlecleucel for acute lymphoblastic leukemia and diffuse large b-cell lymphoma: clinical report
2019	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[Identification of psychosocial practices and interventions that support the adaptation and rehabilitation of adults with Prader-Willi Syndrome]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: best strategies for reducing the risk of severe toxicities caused by dihydropyrimidine dehydrogenase deficiency]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ external condylomas (anogenital warts)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: treatment of mitral regurgitation by a percutaneous device with clip (TMVRc)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: breast tomosynthesis and breast cancer screening]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tisagenlecleucel for the treatment of relapsed or refractory diffuse large B-cell lymphoma]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: approach to managing access to cancer care: a review of the literature and practices]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: The Argus II retinal implant]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: acute exacerbation of chronic obstructive pulmonary disease]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of extracorporeal membrane oxygenation (ECMO) in adults in Quebec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of rifapentine in the treatment of latent tuberculosis infection]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: respiratory multiplex NAAT (8 or more targets)]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: considerations relating to the adoption of the learning health-care system approach, the reflective approach, and audit and feedback in the context of managing chronic diseases and multimorbid states]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: smoking cessation strategies]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: dose banding and dose rounding of antineoplastic agents]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: intensive outpatient services for youths with psychoactive substance use disorders]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: setting safety and conditions for success of vaginal birth after cesarean]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: portrait of the Quebec adult trauma care network: 2013 – 2016]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: relevance of low-dose computed tomography lung cancer screening]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in June 2019: unusual vaginal discharge]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Organization of care and services for stroke to optimize access to endovascular treatment in Quebec]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: pharmacological treatment of nausea in a person receiving palliative care]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: mechanisms for accessing local services]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guidelines and standards: post-tick bite antibiotic prophylaxis to prevent Lyme disease, report in support of the knowledge transfer tools, the Québec’s national medical protocol and the collective prescription template]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the placenta, utility of and indications for the transfer of samples to the anatomical pathology laboratory for analysis]
2019	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: withdrawal management in adult addiction rehabilitation service centres]